News & Media

News
July 11, 2022
Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture
News
July 11, 2022
John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.
News
February 14, 2022
Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.
News
November 22, 2021
Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.
News
September 30, 2021
Andelyn Biosciences Inc. is adding a second laboratory in Dublin, and will move into its headquarters in Ohio State University's Innovation District before construction is complete.
News
September 20, 2016
Sarepta Therapeutics announced yesterday that the FDA has granted accelerated approval for eteplirsen for the treatment of Duchenne muscular dystrophy...